Structure‐Activity Relationships of [Nle4, D‐Phe7]α‐MSH

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Annals of the New York Academy of Sciences

• Publication date

  1993-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/J.1749-6632.1993.TB19749.X
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis and biological activities of fatty acid conjugates of a cyclic lactam alpha-melanotropin.

  1992cited by this paper
• The cloning of a family of genes that encode the melanocortin receptors.

  1992cited by this paper
• Induction of skin tanning by subcutaneous administration of a potent synthetic melanotropin.

  1991cited by this paper
• Stimulation of S91 melanoma tyrosinase activity by superpotent α-melanotropins

  1985cited by this paper
• 4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity.

  1980cited by this paper

• Melanocortins, Melanocortin Receptors and Multiple Sclerosis

  2017cites this paper
• Molecular characterization of human melanocortin-5 receptor ligand-receptor interaction.

  2013cites this paper
• The rise of metal radionuclides in medical imaging: copper-64, zirconium-89 and yttrium-86.

  2011cites this paper
• Design of novel melanocortin receptor ligands: multiple receptors, complex pharmacology, the challenge.

  2011cites this paper
• Bioactive Peptides for Alleviating Illness Anorexia

  2010cites this paper
• Serotype 5 Adenovirus fiber (F7F41S) chimeric vectors incur packaging deficiencies when targeting peptides are inserted into Ad41 short fiber.

  2009cites this paper
• Design, Synthesis, and Biological Evaluation of Melanocortin-1-Receptor Agonists for the Prevention of Skin Cancer

  2008cites this paper
• Structure–Activity Relationships of Melanocortin Agonists Containing the Benzimidazole Scaffold

  2007cites this paper
• Gallium-68-labeled DOTA-rhenium-cyclized alpha-melanocyte-stimulating hormone analog for imaging of malignant melanoma.

  2007cites this paper
• Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization.

  2006cites this paper
• Modified melanocortin tetrapeptide Ac-His-dPhe-Arg-Trp-NH at the arginine side chain with ureas and thioureas.

  2005cites this paper
• Isolation and characterization of antagonist and agonist peptides to the human melanocortin 1 receptor.

  2005cites this paper
• Melanocortin ligands: 30 years of structure–activity relationship (SAR) studies

  2004cites this paper
• Melanocortin Tetrapeptides Modified at the N‐Terminus, His, Phe, Arg, and Trp Positions

  2003cites this paper
• Recent developments in our understanding of melanocortin system in the regulation of food intake

  2003cites this paper
• Design and synthesis of highly potent and selective melanotropin analogues of SHU9119 modified at position 6.

  2002cites this paper
• In Vitro Mutagenesis Studies of Melanocortin Receptor Coupling and Ligand Binding

  2000cites this paper
• Structure activity studies of the melanocortin antagonist SHU9119 modified at the 6, 7, 8, and 9 positions.

  2000cites this paper
• The Proopiomelanocortin System

  1999cites this paper
• Discovery and development of novel melanogenic drugs. Melanotan-I and -II.

  1998cites this paper
• Molecular Basis for the Interaction of [Nle4,d-Phe7]Melanocyte Stimulating Hormone with the Human Melanocortin-1 Receptor (Melanocyte α-MSH Receptor)*

  1997cites this paper
• Melanocortin receptors: identification and characterization by melanotropic peptide agonists and antagonists.

  1996cites this paper
• Binding and internalization of the melanocyte stimulating hormone receptor ligand [Nle4, D-Phe7] alpha-MSH in B16 melanoma cells.

  1996cites this paper